Cargando…
lncRNA CASC2 Enhances (131)I Sensitivity in Papillary Thyroid Cancer by Sponging miR-155
Long noncoding RNA cancer susceptibility candidate 2 (CASC2) has been reported to play an anticancer role in papillary thyroid cancer (PTC). Radioiodine ((131)I) is a common option for the treatment of PTC. However, the role and mechanism of CASC2 in (131)I sensitivity remain unclear. In this study,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591961/ https://www.ncbi.nlm.nih.gov/pubmed/33134385 http://dx.doi.org/10.1155/2020/7183629 |